New Trial Shows Effectiveness of BPaL Regimen for Highly Drug-Resistant TB
TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid. Read Here.
Recent Posts
See AllOn 14 October 2021, the Global Laboratory Initiative and the Global Drug Initiative organise a joint workshop on access to diagnostics, treatment, and care to end TB. Please register for free under th
10
On Thursday, September 23rd RESIST-TB hosted this webinar webinar featuring Dr. Keertan Dheda, who will present the results of the recently-completed NeXT clinical trial for MDR-TB. This study evaluat
70
In Zhytomyr, Ukraine, our teams works with the Regional TB Dispensary to treat patients who have drug-resistant forms of tuberculosis (DR-TB). They are treated with a short course of DR-TB medication
30